Your data is bulletproof.
Is your narrative?
Before your next readout, advisory board, Series C, or partner meeting, every function needs to tell the same story about your data. I build the architecture that makes that inevitable.
10+ years
INSIDE US BIOTECH
You don't have decades to build the coordination infrastructure that pharma built from scratch. I deliver it in months.
You're in the right place if:
Your teams give different answers about your data depending on who's asked.
You've tried agencies, internal meetings, and official decks. Nothing has stuck
You have a high-stakes external conversation approaching and the narrative isn't consistent.
You're spending more time reconciling versions than doing the strategic work you were hired for.
Applications
I work with Phase II-III pre-commercial biotech companies in oncology, neuroscience, immunology, rare disease, and gene therapy.
If your company has raised $30M+ and is approaching a pivotal external moment, we should talk.
"Some of the most impactful professional input I've ever received."
Take The Narrative Risk Assessment
Three People From Your Company.
Three Different Answers.
It happens at advisory boards, partner meetings, and investor calls. Different functions explain the same science differently, and the person across the table notices before your team does.
Five questions. Each one maps to a specific moment where messaging gaps become visible to the people who matter most. Takes less than 5 minutes.
Your Results
Breakdown by Area
This assessment was developed by Yoanne Clovis, PhD, for pre-commercial biotech leaders navigating high-stakes external moments. It identifies the most common messaging fragmentation patterns seen across Phase II and III organizations.
www.yoanneclovis.com · Narrative Risk Protection for Pre-Commercial Biotech
© 2026 Yoanne Clovis LLC. All rights reserved.
"We get compliments on our pitch deck all the time. Potential partners come to the table with a clear understanding of who we are and what we do."
Expertise You Can Trust.
Partnership With Results.
You need more than just a consultant; you need a strategic partner who truly gets both pre-commercial and commercial requirements.
1 Year to Acquisition
I led brand strategy for C2i Genomics C2Intelligence platform, positioning their MRD platform for a successful acquisition by Veracyte.
- Led the development of the platform's visual and verbal expression
- Directed the creation of customer-facing materials
- Supported launch strategy and execution
- Strengthened brand equity, leading to acquisition
Activation Successful Go-to-Market
I helped a biotech pivot from product- to service-based model by delivering a GTM strategy and securing a key CRO partnership in 2 months.
- Conducted rapid market research
- Led Tiger Team of engineers
- Developed brand identity and launch materials
Penetrate New Markets
I helped scale flagship product revenue 5x by building the sales pipeline and inbound engine from the ground up.
- Led product launch and sales development
- Created inbound marketing content
- Built the customer success function
- Increased sales funnel from $0 to six figures
The Strategic Path To Accelerated Growth
We bridge the gap between scientific innovation and market success. We go beyond tactics, building robust, data-driven strategies that transform your market presence.
How it works:
- DIAGNOSE where the story fragments across functions.
- BUILD the unified narrative architecture.
- STRESS-TEST it before you walk into the room
Some of the companies we’ve had the privilege to help grow
Exact Sciences
Personalis
Chan Zuckerberg Initiative
C2i Genomics
MedGenome
Avobis Bio